Font Size:
a
A
A
Keyword [Anti-viral]
Result: 81 - 100 | Page: 5 of 6
81.
Genetically engineered protein modules: Development and applications in anti-viral agent screening and cancer marker detection
82.
Understanding the role of NF-kappaB RelA subunit in TLR and RLR pathways
83.
Psychosocial stress modulation of the murine anti-viral immune response during a primary influenza infection and the impact on immunologic memory
84.
The evolution of the anti-viral OAS1 gene in mice and primates
85.
Functional studies on natural IgM secreting B-1 cells and their roles in innate anti-viral IgM immunity against influenza virus infection
86.
Expression of cellular anti-viral antagonists from vaccinia virus to study the innate immune response and Z -DNA
87.
Expression of the Interleukin (IL)-23 p19 subunit during innate anti-viral immune responses: Cell signaling and promoter analysis
88.
Asthma, childhood exposures and genetics shape anti-viral cytokine responses in humans
89.
Pattern of HLA allele co-expression influences immunodominance of anti-viral CTL responses
90.
Synthesis of A-galceramides, (-)-treprostinil, and design and synthesis of anti-viral agents
91.
De-repression of anti-viral cellular genes and the regulated viral gene expression cascade by the US28- and PP65-deficient mutants of the human cytomegalovirus
92.
Influenza and secondary bacterial pneumonia: Modulation of the host anti-viral immune response and the interferon paradox
93.
The role of macrophages and anti-viral antibodies in West Nile virus pathogenesis
94.
Anti-viral capacity of Quillaja saponaria Molina extract against vaccinia and herpes simplex virus-1
95.
Nucleic Acid Detection in Anti-Viral Responses and Autoimmunity
96.
Transcription factor requirements for the development and anti-viral function of IL-17-secreting CD8 T cells
97.
The role of CCL3 and its receptors in protective anti-viral immunity
98.
Regulation of mammalian mRNA decapping
99.
Nicotine modulation of anti-viral immunity in periadolescent male and female C57BL/6J mice
100.
Targeting uracil exclusion mechanisms for development of anti-viral and anti-cancer therapies
<<First
<Prev
Next>
Last>>
Jump to
